Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Could DehydraTECH CBD be Worth $3 Billion a Year to Lexaria?

PCG Digital -- Hypertension, or high blood pressure as it's commonly known, affects over three million Americans every year and is a primary or contributing cause of death for 25% of them. On a global scale, hypertension kills roughly 7.6 milli on people per year . L...
Featured Submission | March 9, 2021 |

Amgen Shares React Favorably to Enbrel Patent Case Victory

Amgen shares are trading 5–6% higher today on news that the company has won its Enbrel (etanercept) patent court case. On Friday, August 9, 2019, Amgen Inc. (AMGN:NASDAQ) announced that it had won its Enbrel patent case. The company advised that the U.S. District C...
Streetwise Reports | August 14, 2019 |

Aquestive Therapeutics Shares Up on Pipeline Update and Raised Full-Year 2019 Guidance

Aquestive Therapeutics shares traded 20% higher today after the firm reported Q3/19 earnings and raised its FY/19 guidance. The firm states it expects to complete its NDA for Libervant buccal film near the end of this month. Yesterday afternoon, specialty pharmaceutic...
Streetwise Reports | November 7, 2019 |

Baudax Shares Rise as FDA Approves NDA for Its Non-Opioid Pain Medication

Shares of Baudax Bio traded more than 20% higher and set a new 52-week high price after reporting that the FDA approved the company's non-opioid ANJESO™ drug for management of moderate to severe pain. Specialty pharmaceutical company Baudax Bio Inc. (BXRX:N...
Streetwise Reports | February 24, 2020 |

Natural gas trade trumps gold's comeback

In our report published November 20, 2009, we recommended immediate action be taken regarding gold positions in general and in a particularly profitable, zero premium trade in silver that we had prescribed several weeks prior. In the face of a steadily rising bullion price w...
Matt McAbby | October 28, 2012 |

A Life Sciences Project Accelerator Kicks into High Gear

XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTC: XPHYF) has been a hot story lately, especially in Germany, due to its recent commercialization of a super-fast PCR test kit for definitively diagnosing COVID-19 infections in point-of-care settings. The company rec...
Marc Davis | May 10, 2021 |

East-West Trade War: Never Take a Knife to a Gunfight

It's a funny thing that happens when the stress of financial insolvency bubbles up to the surface. Decisions once considered "routine" (like brushing one's teeth or walking one's dog) suddenly have life-or-death outcomes, complete with cold sweats, sleepless nights and ...
Streetwise Reports | October 11, 2019 |

Solar Energy Firm Signs Large Deal for New York Project, 12–15 Times Its Average Size

This project, along with two other new projects, increases the company's order backlog by 65%. UGE International Ltd. (UGE:TSX.V; UGEIF:OTCQB) announced the signing of an agreement for its largest U.S. project ever, a 6.6 MW project in Westchester County,...
Streetwise Reports | April 3, 2020 |

An Emerging Medical Market Play with Great Opportunity

(Image via Bioasis Technologies Inc.) Biopharmaceutical Company Bioasis Technologies Inc. ( TSX-V: BTI , OTCQB: BIOAF , Forum ) is developing its proprietary xB 3TM platform technology to deliver therapeutics across the blood brain barrier (BBB) and int...
Stockhouse Editorial | July 28, 2020 |

Buzz on the Bullboards: One Step Closer to a Canadian-Made COVID Vaccine?

(Image via Theralase Technologies Inc.) Clinical-stage pharmaceutical company Theralase Technologies Inc. ( TSX-V: TLT , Forum ) has demonstrated proof-of-concept for its Canadian-made COVID-19 vaccine. In collaboration with the University of Manitoba (UM), t...
Stockhouse Editorial | February 9, 2022 |
1 2